Cargando…

Effects of human arylamine N-acetyltransferase I knockdown in triple-negative breast cancer cell lines

Expression of human arylamine N-acetyltransferase I (NAT1) has been associated with various cancer subtypes and inhibition of this enzyme with small molecule inhibitors or siRNA affects cell growth and survival. Here, we have investigated the role of NAT1 in the invasiveness of breast cancer cells b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tiang, Jacky M, Butcher, Neville J, Minchin, Rodney F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2015
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402071/ https://www.ncbi.nlm.nih.gov/pubmed/25627111 http://dx.doi.org/10.1002/cam4.415

Ejemplares similares

RNAi-Mediated Knock-Down of Arylamine N-acetyltransferase-1 Expression Induces E-cadherin Up-Regulation and Cell-Cell Contact Growth Inhibition
por: Tiang, Jacky M., et al.
Publicado: (2011)

Trimodal distribution of arylamine N-acetyltransferase 1 mRNA in breast cancer tumors: association with overall survival and drug resistance
por: Minchin, Rodney F., et al.
Publicado: (2018)

Arylamine N-acetyltransferase 1 protects against reactive oxygen species during glucose starvation: Role in the regulation of p53 stability
por: Wang, LiLi, et al.
Publicado: (2018)

Effect arylamine N-acetyltransferase 1 on morphology, adhesion, migration, and invasion of MDA-MB-231 cells: role of matrix metalloproteinases and integrin αV
por: Li, Pengcheng, et al.
Publicado: (2020)

Arylamine N-acetyltransferase 1 deficiency inhibits drug-induced cell death in breast cancer cells: switch from cytochrome C-dependent apoptosis to necroptosis
por: McAleese, Courtney E., et al.
Publicado: (2022)

5-Methyl-Tetrahydrofolate and the S-Adenosylmethionine Cycle in C57BL/6J Mouse Tissues: Gender Differences and Effects of Arylamine N-Acetyltransferase-1 Deletion
por: Witham, Katey L., et al.
Publicado: (2013)

Arylamine N-Acetyltransferases in Mycobacteria
por: Sim, Edith, et al.
Publicado: (2008)

Arylamine N-acetyltransferase 2 Polymorphisms and the Risk of Endometriosis
por: Fayez, Diman, et al.
Publicado: (2018)

Arylamine N-acetyltransferase 2 Polymorphisms and the Risk of Endometriosis
por: Barra, Fabio, et al.
Publicado: (2018)

Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding
por: Laurieri, Nicola, et al.
Publicado: (2014)

Kinetic characterisation of arylamine N-acetyltransferase from Pseudomonas aeruginosa
por: Westwood, Isaac M, et al.
Publicado: (2007)

Biochemical Characterization of Arylamine N-acetyltransferases From Vibrio vulnificus
por: Liu, Xinning, et al.
Publicado: (2021)

Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery
por: Sim, E, et al.
Publicado: (2014)

Polymorphisms of arylamine N-acetyltransferase2 and risk of lung and colorectal cancer
por: Mahasneh, Amjad, et al.
Publicado: (2012)

Subcellular Protein Labeling by a Spatially Restricted Arylamine N-Acetyltransferase
por: Kleinpenning, Fleur, et al.
Publicado: (2018)

Arylamine N-Acetyltransferase 1 Activity is Regulated by the Protein Acetylation Status
por: Salazar-González, Raúl A., et al.
Publicado: (2022)

Humans and Chimpanzees Display Opposite Patterns of Diversity in Arylamine N-Acetyltransferase Genes
por: Vangenot, Christelle, et al.
Publicado: (2019)

Correction to Subcellular Protein Labeling by a Spatially Restricted Arylamine N-Acetyltransferase
por: Kleinpenning, Fleur, et al.
Publicado: (2019)

Unexpected Acetylation of Endogenous Aliphatic Amines by Arylamine N‐Acetyltransferase NAT2
por: Conway, Louis P., et al.
Publicado: (2020)

N-hydroxyarylamine O-acetyltransferase of Salmonella typhimurium: proposal for a common catalytic mechanism of arylamine acetyltransferase enzymes.
por: Watanabe, M, et al.
Publicado: (1994)

Arylamine N-acetyltransferase 2 genotype-dependent N-acetylation of isoniazid in cryopreserved human hepatocytes
por: Doll, Mark A., et al.
Publicado: (2017)

Mechanism by which arylamine N-acetyltransferase 1 ablation causes insulin resistance in mice
por: Camporez, João Paulo, et al.
Publicado: (2017)

Development and characterization of two human triple‐negative breast cancer cell lines with highly tumorigenic and metastatic capabilities
por: Su, Yanrong, et al.
Publicado: (2016)

Polymorphisms in the Human Cytochrome P450 and Arylamine N-Acetyltransferase: Susceptibility to Head and Neck Cancers
por: Khlifi, Rim, et al.
Publicado: (2013)

Folate-dependent hydrolysis of acetyl-coenzyme A by recombinant human and rodent arylamine N-acetyltransferases
por: Stepp, Marcus W., et al.
Publicado: (2015)

Treatment of Rats with Apocynin Has Considerable Inhibitory Effects on Arylamine N-Acetyltransferase Activity in the Liver
por: Francis, Sheena, et al.
Publicado: (2016)

A pilot study of the modulation of sirtuins on arylamine N-acetyltransferase 1 and 2 enzymatic activity
por: Turiján-Espinoza, Eneida, et al.
Publicado: (2018)

Human arylamine N-acetyltransferase 2 genotype-dependent protein expression in cryopreserved human hepatocytes
por: Salazar-González, Raúl A., et al.
Publicado: (2020)

Dataset for proteomic analysis of arylamine N-acetyltransferase 1 knockout MDA-MB-231 breast cancer cells
por: Hong, Kyung U., et al.
Publicado: (2022)

Identification of new arylamine N-acetyltransferases and enhancing 2-acetamidophenol production in Pseudomonas chlororaphis HT66
por: Guo, Shuqi, et al.
Publicado: (2020)

Osteoprotegerin expression in triple-negative breast cancer cells promotes metastasis
por: Weichhaus, Michael, et al.
Publicado: (2014)

Human Arylamine N-Acetyltransferase 1 (NAT1) Knockout in MDA-MB-231 Breast Cancer Cell Lines Leads to Transcription of NAT2
por: Carlisle, Samantha M., et al.
Publicado: (2022)

Proteomic analysis of arylamine N-acetyltransferase 1 knockout breast cancer cells: Implications in immune evasion and mitochondrial biogenesis
por: Hong, Kyung U., et al.
Publicado: (2022)

Fascin‐1 as a novel diagnostic marker of triple‐negative breast cancer
por: Wang, Chao‐Qun, et al.
Publicado: (2016)

Arylamine N-Acetyltransferase 2 (NAT2) Genetic Diversity and Traditional Subsistence: A Worldwide Population Survey
por: Sabbagh, Audrey, et al.
Publicado: (2011)

Arylamine N-acetyltransferase polymorphisms in Han Chinese patients with ankylosing spondylitis and their correlation to the adverse drug reactions to sulfasalazine
por: Hou, Zhi-duo, et al.
Publicado: (2014)

Two activating mutations of MPL in triple‐negative myeloproliferative neoplasms
por: Xie, Juan, et al.
Publicado: (2019)

Human N-Acetyltransferase 1 and 2 Differ in Affinity Towards Acetyl-Coenzyme A Cofactor and N-Hydroxy-Arylamine Carcinogens
por: Hein, David W., et al.
Publicado: (2022)

Protein arginine methyltransferase 5: A novel therapeutic target for triple‐negative breast cancers
por: Vinet, Mathilde, et al.
Publicado: (2019)

OSW‐1 inhibits tumor growth and metastasis by NFATc2 on triple‐negative breast cancer
por: Ding, Xiaorong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g8u8p6ktk9fvomtobcutkuasb5